OCT 23, 2020 6:00 AM PDT

Follow Your Heart: A Genetic Predictor of Cardiovascular Disease

WRITTEN BY: Tara Fernandez

Cardiovascular disease is the leading cause of death globally, resulting in the loss of nearly 18 million lives each year. Earlier interventions through drug prescriptions or lifestyle changes are our best hope for saving lives. Researchers at Massachusetts General Hospital have identified a biomarker in the blood that can help pinpoint individuals most at risk of developing heart disease earlier, allowing them to make these changes sooner. The protein, called lipoprotein(a), can be measured easily using standard serological or genetic tests.

Lipoprotein(a) is a type of low-density lipoprotein (LDL)-like lipoprotein. Unlike LDL cholesterol (often referred to as the “bad” cholesterol due to its link with an increased risk of getting a heart attack or stroke), lipoprotein(a) has, until now, been under-recognized as a biomarker for heart disease. As a result, its blood levels are rarely measured as part of a patient’s blood work.

Pradeep Natarajan, MD is the lead investigator and senior author of the study that aims to shift the focus onto lipoprotein(a) as a valuable genetic test for cardiovascular disease. “Our work demonstrates that genetic risk scoring of lipoprotein(a) offers risk prediction of atherosclerotic cardiovascular disease that’s comparable to directly measured lipoprotein(a),” said Natarajan.

“We learned that genetic determinants of elevated lipoprotein(a) may help identify the most effective medication regimen for cardiovascular disease prevention.”

A person’s lipoprotein(a) levels are heavily influenced (up to 95 percent) by genetics as opposed to diet and physical activity levels. Those with a genetic predisposition to have over 50 milligrams per deciliter lipoprotein(a) concentrations in the blood, are 50 percent more likely to develop cardiovascular conditions.

“Using genetic factors enhances our ability to identify at-risk individuals for cardiovascular disease who could benefit from earlier preventive strategies,” explained Natarajan, who added, “At the same time, genetic testing could help identify candidates for clinical trials who are critical to discovering innovative new therapies to address conditions like elevated lipoprotein(a) and related cardiovascular disease risks.”

 

 

Sources: Massachusetts General Hospital, JAMA Cardiology.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
APR 21, 2021
Clinical & Molecular DX
Miniature Implant Checks Oxygen Levels in Internal Organs
APR 21, 2021
Miniature Implant Checks Oxygen Levels in Internal Organs
  Berkeley researchers have created the next generation of deep tissue oxygen sensors: A tiny, wireless device that ...
MAY 03, 2021
Health & Medicine
The Challenges and Advantages of Direct PCR Amplification
MAY 03, 2021
The Challenges and Advantages of Direct PCR Amplification
  Testing for COVID-19 continues to be one of the most important tools in the global fight to slow and reduce the i ...
MAY 09, 2021
Genetics & Genomics
Another Neurodevelopmental Disorder is Discovered
MAY 09, 2021
Another Neurodevelopmental Disorder is Discovered
Researchers are identifying more rare disorders because of advances in genetic sequencing technologies, which have made ...
JUN 08, 2021
Genetics & Genomics
Primers and Probes to Assay for SARS-CoV-2 Variants in Research Samples
JUN 08, 2021
Primers and Probes to Assay for SARS-CoV-2 Variants in Research Samples
Today, many scientists are investigating SARS-CoV-2 variants in their research projects. In order to facilitate screenin ...
JUL 19, 2021
Cardiology
Immune Proteins & Blood Clots May be Connected to Psychosis Development
JUL 19, 2021
Immune Proteins & Blood Clots May be Connected to Psychosis Development
Researchers are pointing out the associations between blood clotting disruptions and the front line immune system, and t ...
SEP 06, 2021
Cancer
A New Biomarker to Personalize Breast Cancer Therapy
SEP 06, 2021
A New Biomarker to Personalize Breast Cancer Therapy
The American Cancer Society estimates that over 280,000 women in the United States will be diagnosed with breast cancer ...
Loading Comments...